Human Papillomavirus Epidemiology in Nigeria

NCT00804466CompletedNAINTERVENTIONAL

Summary

Key Facts

Lead Sponsor

National Cancer Institute (NCI)

Enrollment

1466

Start Date

2009-07-06

Completion Date

2019-12-30

Study Type

INTERVENTIONAL

Official Title

Epidemiologic and Molecular Features of Cervical Cancer in Nigeria - Project Itoju (Care)

Interventions

OncoE6EVA System

Conditions

Human Papillomavirus 18Cervical Intraepithelial NeoplasiaHuman Papillomavirus 16Uterine Cervical Neoplasms

Eligibility

Age Range

30 Years – 49 Years

Sex

FEMALE

* INCLUSION CRITERIA:
* Females who are 15 years to 99 years of age

EXCLUSION CRITERIA:

* Previous hysterectomy
* Current pregnancy
* Inability to give informed consent

Outcome Measures

Primary Outcomes

Sensitivity of triage methods

Cervical Histopathology

Time frame: cross-sectional

Locations

Obafemi Awolowo University Teaching Hospital, Ile-Ife, Nigeria

Human Papillomavirus Epidemiology in Nigeria